Vir Biotechnology Inc. (VIR) Tops Q2 EPS by 14c
Tweet
Share
E-mail
Get Alerts VIR Hot Sheet
Join SI Premium – FREE
Vir Biotechnology Inc. (NASDAQ: VIR) reported Q2 EPS of $0.47, $0.14 better than the analyst estimate of $0.33. Revenue for the quarter came in at $238.94 million versus the consensus estimate of $135.88 million.
For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yatsen Holding (YSG) Reports Q2 Loss of $0.16
- Guggenheim Reiterates Buy Rating on MongoDB (MDB)
- KKR hires two managing directors to expand European credit unit
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
